NO933341D0 - Forbindelse mot kreft - Google Patents

Forbindelse mot kreft

Info

Publication number
NO933341D0
NO933341D0 NO1993933341A NO933341A NO933341D0 NO 933341 D0 NO933341 D0 NO 933341D0 NO 1993933341 A NO1993933341 A NO 1993933341A NO 933341 A NO933341 A NO 933341A NO 933341 D0 NO933341 D0 NO 933341D0
Authority
NO
Norway
Prior art keywords
power
connection
Prior art date
Application number
NO1993933341A
Other languages
English (en)
Other versions
NO933341L (no
Inventor
Graham Michael Fraser Bisset
Ann Lesley Jackman
Duncan Ian Jodrell
Original Assignee
British Tech Group
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group, Ici Plc filed Critical British Tech Group
Publication of NO933341D0 publication Critical patent/NO933341D0/no
Publication of NO933341L publication Critical patent/NO933341L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO933341A 1991-03-19 1993-09-20 Fordindelser mot kreft NO933341L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919105771A GB9105771D0 (en) 1991-03-19 1991-03-19 Anti-cancer compounds
PCT/GB1992/000476 WO1992016512A1 (en) 1991-03-19 1992-03-18 Anti-cancer compounds

Publications (2)

Publication Number Publication Date
NO933341D0 true NO933341D0 (no) 1993-09-20
NO933341L NO933341L (no) 1993-11-18

Family

ID=10691801

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933341A NO933341L (no) 1991-03-19 1993-09-20 Fordindelser mot kreft

Country Status (18)

Country Link
US (1) US5444061A (no)
EP (1) EP0509643A1 (no)
JP (1) JPH06505974A (no)
AU (1) AU655970B2 (no)
CA (1) CA2106583A1 (no)
CZ (1) CZ195393A3 (no)
FI (1) FI934106A (no)
GB (2) GB9105771D0 (no)
HU (1) HUT67177A (no)
IE (1) IE920853A1 (no)
IL (1) IL101281A0 (no)
MX (1) MX9201183A (no)
NO (1) NO933341L (no)
NZ (1) NZ242023A (no)
SK (1) SK100993A3 (no)
TW (1) TW203608B (no)
WO (1) WO1992016512A1 (no)
ZA (1) ZA921985B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9205907D0 (en) * 1992-03-18 1992-04-29 Cancer Res Inst Royal Anti-cancer compounds
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
GB9408936D0 (en) * 1994-05-05 1994-06-22 Cancer Res Inst Anti-cancer compounds
DE69613985T2 (de) * 1995-08-30 2002-06-13 G.D. Searle & Co., Chicago Meta-guanidine, harnstoff, thioharnstoff oder azacyklische aminobenzoesäure-derivate als integrin antagonisten
GB9904275D0 (en) 1999-02-24 1999-04-21 Cancer Res Campaign Tech Anti-cancer compounds
US7230000B1 (en) 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US7671200B2 (en) * 1999-10-27 2010-03-02 Cytokinetics, Inc. Quinazolinone KSP inhibitors
AU2003213092A1 (en) * 2002-02-15 2003-09-09 Smithkline Beecham Corporation Syntheses of quinazolinones
JP2005530785A (ja) * 2002-05-09 2005-10-13 サイトキネティクス・インコーポレーテッド 化合物、組成物、及び方法
BR0309892A2 (pt) * 2002-05-09 2011-04-05 Cytokinetics Inc composto, composição, métodos para modular a atividade da cinesina de ksp, para inibir a ksp, e para o tratamento de uma doença proliferativa celular, e, uso de um composto
US7038048B2 (en) * 2002-05-23 2006-05-02 Cytokinetics, Inc. 3H-pyridopyrimidin-4-one compounds, compositions, and methods of their use
EP1556357A4 (en) * 2002-06-14 2006-09-13 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
US20030236430A1 (en) * 2002-06-21 2003-12-25 Allen David Robert Preparation of protected amino acids
AU2003256805A1 (en) * 2002-07-23 2004-02-09 Cytokinetics, Inc. Compounds compositions and methods
US20040048853A1 (en) * 2002-08-21 2004-03-11 Gustave Bergnes Compounds, compositions, and methods
EP1558083A4 (en) * 2002-09-30 2008-04-16 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
JP2007510652A (ja) * 2003-11-03 2007-04-26 サイトキネティクス・インコーポレーテッド ピリミジン−４−オン化合物、組成物、および方法
EP1680420A4 (en) * 2003-11-07 2008-09-24 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
JP2007513154A (ja) * 2003-12-08 2007-05-24 サイトキネティクス・インコーポレーテッド 化合物、組成物及び方法
JP5693950B2 (ja) 2007-04-11 2015-04-01 メルク エ カンパニー １８ｆ標識葉酸
CA2959208C (en) 2014-08-29 2023-09-19 Tes Pharma S.R.L. Pyrimidine derivatives and their use as inhibitors of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase
EP3846793B1 (en) 2018-09-07 2024-01-24 PIC Therapeutics, Inc. Eif4e inhibitors and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2065653B (en) * 1979-12-19 1983-03-09 Nat Res Dev Anti-cancer quinazoline derivatives
GB8513754D0 (en) * 1985-05-31 1985-07-03 Jones T R Anti-cancer quinazoline derivatives
US4746659A (en) * 1985-12-30 1988-05-24 Sri International Diastereomers of 10-alkyl-10-deazaminopterins and process for preparing the same
US5187167A (en) * 1986-03-27 1993-02-16 Imperial Chemical Industries Plc Pharmaceutical compositions comprising quinazolin-4-one derivatives
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
GB8625019D0 (en) * 1986-10-18 1986-11-19 Wellcome Found Compounds
GB8707053D0 (en) * 1987-03-25 1987-04-29 Ici Plc Anti-tumour agents
US4767761A (en) * 1987-11-04 1988-08-30 Dana-Farber Cancer Institute, Inc. Ornithine derivatives and their use as methotrexate-resistant cell inhibitors
GB8727737D0 (en) * 1987-11-26 1987-12-31 Ici Plc Antitumour agents
GB8809978D0 (en) * 1988-04-27 1988-06-02 Ici Plc Anti-tumour agents
US5252573A (en) * 1988-12-15 1993-10-12 Imperial Chemical Industries Plc Anti-tumor agents
GB8829296D0 (en) * 1988-12-15 1989-01-25 Ici Plc Anti-tumour compounds
US4996207A (en) * 1990-01-18 1991-02-26 Nair Madhavan G Three new non-polyglutamatable deazaaminopterins
DE69111891T2 (de) * 1990-05-17 1996-04-04 Smith & Nephew United Inc Elektrisch leitender und adstringierender Film sowie filmbildende Zusammensetzung zur Verwendung auf der Haut.
AU640016B2 (en) * 1990-05-30 1993-08-12 Imperial Chemical Industries Plc Hydroquinazoline derivatives

Also Published As

Publication number Publication date
TW203608B (no) 1993-04-11
WO1992016512A1 (en) 1992-10-01
NO933341L (no) 1993-11-18
ZA921985B (en) 1993-09-20
GB2253849B (en) 1995-01-18
GB9105771D0 (en) 1991-05-01
HUT67177A (en) 1995-02-28
JPH06505974A (ja) 1994-07-07
CA2106583A1 (en) 1992-09-20
MX9201183A (es) 1994-06-30
NZ242023A (en) 1993-12-23
FI934106A (fi) 1993-11-18
CZ195393A3 (en) 1994-07-13
GB2253849A (en) 1992-09-23
IL101281A0 (en) 1992-11-15
FI934106A0 (fi) 1993-09-20
IE920853A1 (en) 1992-09-23
HU9302636D0 (en) 1993-12-28
US5444061A (en) 1995-08-22
GB9205906D0 (en) 1992-04-29
EP0509643A1 (en) 1992-10-21
AU655970B2 (en) 1995-01-19
AU1371692A (en) 1992-10-21
SK100993A3 (en) 1994-08-10

Similar Documents

Publication Publication Date Title
NO933341D0 (no) Forbindelse mot kreft
DE69126540D1 (de) Kraftwandler
BR9205871A (pt) Luz de energização solar
KR900012149A (ko) 파워 세이브 시스템
DE69221358D1 (de) Spannungserhöhende Schaltleistungswandlung
DE3855074D1 (de) Hochleistungsstrahler
FI923370A (fi) Axelanslutningar med kompositmaterial mot metall
DE69309021D1 (de) Stromversorgungsverlustsensor
DE69123928D1 (de) Leistungswandlungsgerät
DE69210940D1 (de) Leistungsumrichter
KR900008752A (ko) 전력변환장치
DK286089D0 (da) Kobling til ostomipose
DE69215527D1 (de) Verbesserungen an kupplungsvorrichtungen
DK272690A (da) Indretning til lettelse af defaekation
KR910000887U (ko) 윈드카아 동력장치
DK0481353T3 (da) Højeffektstrømforsyning
KR920003505U (ko) 전력변환회로
KR890018236U (ko) 전원선 접속구
SE9103393D0 (sv) Hjaelpmedel mot inkontinens
KR930013475U (ko) 동력 전달 장치
NO934819L (no) Effektomformer
KR920018898U (ko) 소형 동력 흡충기
DK93491A (da) Selvemulgerende esterforbindelser
KR900007214A (ko) 팩시밀리의 수신모드 자동절환방법
KR900010904U (ko) 역전원에 따른 시스템 보호회로